The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique: prevalence and effect of social shielding von Cleaton, N., Raizada, S., Barkham, N., Venkatachalam, S., Sheeran, T. P., Adizie, T., Sapkota, H., Singh, B. M., Bateman, J.

Volltext

Identification of risk factors for future fracture in patients following distal forearm fracture von MULHERIN, D, WILLIAMS, S, SMITH, J. A, EDWARDS, J, SHEERAN, T. P, PRICE, T

Volltext

Sjögren's syndrome in women presenting with chronic dyspareunia von Mulherin, Diarmuid M., Sheeran, Thomas P., Kumararatne, Dinakantha S., Speculand, Bernard, Luesley, David, Situnayake, R. Deva

Volltext

Measurement of natural killer cell cytotoxicity by area under a cytotoxic curve: A method suitable for rheumatoid arthritis von Sheeran, T.P., Jackson, F.R., Dawes, P.T., Collins, M., Shadforth, M.F.

Volltext

AB0370 Real Life Experience with Abatacept in Patients with Rheumatoid Arthritis from A Regional Centre in UK von Joshi, P., Sheeran, T.P., Venkatachalam, S., Roskell, S.

Volltext

Enthesopathy index in ankylosing spondylitis von Dawes, P T, Sheeran, T P, Beswick, E J, Hothersall, T E

Volltext

Chest pain--a common feature of ankylosing spondylitis von Dawes, P. T., Sheeran, T. P., Hothersall, T. E.

Volltext

Clinical image: Hidden costs of anti–tumor necrosis factor α therapy von Mulherin, D., Sheeran, T. P.

Volltext

Comparison and evaluation of a disease activity index for use in patients with rheumatoid arthritis von DAVIS, M. J, DAWES, P. T, FOWLER, P. D, SHEERAN, T. P, SHADFORTH, M. F, ZIADE, F, COLLINS, M, JONES, P

Volltext

Venostasis, subclinical vasculitis and Von Willebrand factor antigen von BLANN, A. D, WAINWRIGHT, A. C, SHEERAN, T. P, EMERY, P

Volltext

COMPARISON AND EVALUATION OF A DISEASE ACTIVITY INDEX FOR USE IN PATIENTS WITH RHUEMATIOD ARTHRITIS von DAVIS, M. J., DAWES, P. T., FOWLER, P. D., SHEERAN, T. P., SHADFORTH, M. F., ZIADE, F., COLLINS, M., JONES, P.

Volltext

Hypocomplementaemia, C3 Nephritic Factor and Type III Mesangiocapillary Glomerulonephritis Progressing to Systemic Lupuis Erythematosus von SHEERAN, T.P., WHITE, R.H.R., RAAFAT, F., JACKSON, M.A., KUMARARATNE, D.S., SITUNAYAKE, R.D.

Volltext

Hypocomplementaemia, C3 nephritic factor and type III mesangiocapillary glomerulonephritis progressing to systemic lupus erythematosus von Sheeran, T P, White, R H R, Raafat, F, Jackson, M A

Volltext

Clinical image: Hidden costs of anti-tumor necrosis factor a therapy von MULHERIN, D, SHEERAN, T. P

Volltext

Combination therapy in rheumatoid arthritis--study design von Fowler, P D, Dawes, P T, Sheeran, T P, Shadforth, M F

Volltext

VENOSTASIS, SUBCLINICAL VASCULITIS AND VON WILLEBRAND FACTOR ANTIGEN von BLANN, A. D., WAINWRIGHT, A. C., SHEERAN, T. P., EMERY, P.

Volltext

Combination Therapy in Rheumatoid Arthritis—Study Design von FOWLER, P. D., DAWES, P. T., SHEERAN, T. P., SHADFORTH, M. F.

Volltext

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil von Akhtar, Mumina, Nair, Nisha, Carter, Lucy M, Vital, Edward M, Sutton, Emily, McHugh, Neil, Bruce, Ian N, Reynolds, John A

Volltext

Hypocomplementaemia, C3 nephritic factor and type III mesangiocapillary glomerulonephritis progressing to systemic lupus erythematosus von Sheeran, T P, White, R H, Raafat, F, Jackson, M A, Kumararatne, D S, Situnayake, R D

Volltext

Hypocomplementaemia, C3 nephritic factor and type III mesangiocapillary glomerulonephritis progressing to systemic lupus erythematosus von Sheeran, T P, White, R H, Raafat, F, Jackson, M A, Kumararatne, D S, Situnayake, R D

Volltext